News

Valneva regains control of key R&D assets, strengthens financial outlook with $23 million CEPI chikungunya grant

Read more

Valneva SE (“Valneva” or “the Company”), a biotech company developing and commercializing vaccines for infectious diseases with major unmet needs,...

Read more

Valneva SE (“Valneva”), a biotech company developing and commercializing vaccines for infectious diseases with major unmet needs, and the Coalition...

Read more

Advances in sequencing technology have allowed scientists to peer inside living cells and follow the fate of small RNAs. The expedition has uncovered...

Read more

Researchers at IMBA-Institute of Molecular Biotechnology of the Austrian Academy of Sciences show how neural stem cells determine their “age”, or...

Read more

The VDRC is with 27.000 RNAi lines of Drosophila melanogaster, which cover 91 % of the whole genome, the largest center providing RNAi lines...

Read more

Valneva SE (“Valneva” or “the Company”), a biotech company developing and commercializing vaccines for infectious diseases with major unmet needs,...

Read more

Mitosis is the process by which the genetic information encoded on chromosomes is equally distributed to two daughter cells, a fundamental feature of...

Read more

An international team led by Jijie Chai and Cyril Zipfel that included PhD Student Katarzyna Parys and Youssef Belkhadir from the GMI identified a...

Read more

Together with Corinna Dawid from the Technical University of Munich, Youssef received this award for their work on how plants use essential fatty...

Read more

The patent strengthens the unique position of ARESdb, Ares Genetics’ knowledge base of antimicrobial resistance genetics.

Read more